(3aS,4S,6S,7aR)-2-Isobutyl-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborole, 95.0%, 10g

N-Hidroxisuccinimida, mínimo 99 %, para síntesis, 100 g, envase de vidrio

(S)-(-)-2-Hydroxy-tert-butylacetic acid, 95.0%, 5g

3-(2-((1R,4aS,5R,8aS)-5,8a-Dimethyl-2-methylene-5-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)decahydronaphthalen-1-yl)ethyl)furan-2(5H)-one, 98%, 5mg

3-(2-ethylphenoxy)-N-methyl-1-propanamine, 95.0%, 250mg

(S)-tert-Butyl (3-oxocyclopentyl)carbamate, 95.0%, 100mg

7-Bromo-8-chloro-1,2,3,4-tetrahydroisoquinoline, 98%, 100mg

3-Oxetaneacetonitrile, 95%, 5g

Ethyl 3-cyclopropyl-1H-pyrazole-4-carboxylate, 95.0%, 250mg

2-Bromo-6-(bromomethyl)pyridine, 95.0%, 10g

4-Biphenyl-3',4'-difluoro-acetic acid, 97.0%, 1g

MEROPENEM TRIHYDRATE, 97%, 1g

4,4'-Bis(trifluoromethyl)-2,2'-bipyridine, 97.0%, 250mg